Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis

Background: Data on the effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in reducing cardiovascular (CV) risk in patients undergoing peritoneal dialysis (PD) are limited. We investigated the association between ACEI/ARB use and CV outcomes...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Nephrol Dial Transplant
Glavni autori: Shen, Jenny I., Saxena, Anjali B., Montez-Rath, Maria E., Chang, Tara I., Winkelmayer, Wolfgang C.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837596/
https://ncbi.nlm.nih.gov/pubmed/27190342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw053
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items